Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 4/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.65 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.65 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.61 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.61 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL385995 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385978 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL386248 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL383519 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385481 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL1477766 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385116 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL11995515 | 1.00 | PRKCA (0.80) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL385929 | 0.98 | PRKCA (0.77) | PRKCAALDH1A1LMNAPRKCEPRKCQ | |
| SCHEMBL3918449 | 0.97 | PRKCA (0.85) | PRKCAALDH1A1LMNAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3056541-B1 | ALIPHATIC POLYESTER RESIN COMPOSITION AND ALIPHATIC POLYESTER RESIN MOLDED ARTICLE | KANEKA CORP (JP) | 2019-11-06 | — | — | EP | claimed |
| US-20180360706-A1 | Delivery Particles | PROCTER & GAMBLE (US) | 2018-12-20 | — | — | US | claimed |
| EP-2748275-B1 | METHODS OF FLUID LOSS CONTROL, DIVERSION, AND SEALING USING DEFORMABLE PARTICULATES | HALLIBURTON ENERGY SERVICES INC (US) | 2016-09-28 | — | — | EP | claimed |
| EP-2421930-B1 | METHODS AND COMPOSITION RELATING TO THE CHEMICAL DEGRADATION OF DEGRADABLE POLYMERS | HALLIBURTON ENERGY SERVICES INC (US) | 2015-08-12 | — | — | EP | claimed |
| EP-2563508-A2 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2013-03-06 | — | — | EP | claimed |
| US-20110268802-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-11-03 | — | — | US | claimed |
| WO-2010079468-A2 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| EP-4747001-A2 | SILICA CAPSULES | The Procter & Gamble Company (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260042933-A1 | Formulation For Simultaneous Rejuvenation And Protection Of The Interior Fibers And Exterior Surfaces Of Wood | WINGET RICHARD (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250368890-A1 | ANTI-CAKING OR BLOCKING AGENT FOR TREATING SOLID ACID PRECURSOR ADDITIVES USED IN TREATING SUBTERRANEAN FORMATIONS | LYONDELLBASELL ADVANCED POLYMERS INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-12478942-B2 | Methods of making capsules | THE PROCTER & GAMBLE COMPANY (US) | 2025-11-25 | — | — | US | disclosed |
| EP-3955890-B1 | CAPSULES | PROCTER & GAMBLE (US) | 2025-07-16 | — | — | EP | disclosed |
| US-12343696-B2 | Capsules | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-01 | — | — | US | disclosed |
| US-20060060997-A1 | Polarizing plate protective film and manufacturing method for the same | KONICA MINOLTA OPTO, INC. | 2006-03-23 | — | — | US | disclosed |
| WO-2006013869-A1 | THERMOPLASTIC FILM AND METHOD OF PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2006-02-09 | — | — | WO | disclosed |
| WO-2006006724-A1 | THERMOPLASTIC FILM AND METHOD OF MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2006-01-19 | — | — | WO | disclosed |
| US-20060004192-A1 | Method of preparing a cellulose acylate, cellulose acylate film, polarizing plate, and liquid crystal display device | FUJI PHOTO FILM CO., LTD. | 2006-01-05 | — | — | US | disclosed |
| EP-0101046-B1 | METHODS, COMPOSITIONS AND ELEMENTS FOR THE DETERMINATION OF LIPASE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-08-06 | — | — | EP | disclosed |
| US-4555483-A | GLYCEROL TRIESTER SUBSTRATE; ESTERASE ENZYME; DETECTING RATE OF FORMATION OF GLYCEROL | EASTMAN KODAK COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| EP-0101046-A1 | Methods, compositions and elements for the determination of lipase | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360706-A1 | Delivery Particles | LIPA, CHMP4B, ABCB4 | PRKCA 4196/4885ALDH1A1 1320/4885LMNA 1590/4885 |
| US-20110268802-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | PRKCA 4215/4885ALDH1A1 1476/4885LMNA 1581/4885 |
| US-20260042933-A1 | Formulation For Simultaneous Rejuvenation And Protection Of The Interior Fibers And Exterior Surfaces Of Wood | PPARA, ELOVL1, ELOVL3 | PRKCA 2717/4885ALDH1A1 1843/4885LMNA 428/4885 |
| US-12478942-B2 | Methods of making capsules | FUT6, FUT5, LIPA | PRKCA 4627/4885ALDH1A1 1603/4885LMNA 1124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.